Overview

Use of Granulocyte Colony-stimulating Factor for the Treatment of Recurrent Implantation Failure in IVF Patients

Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The investigators use granulocyte colony-stimulating factor (GCSF) for the treatment of recurrent implantation failure in IVF patient with cause unknown or due to thin endometrium. Several studies showed that GCSF improves embryo development and implantation and increase pregnancy rate.
Phase:
Phase 1
Details
Lead Sponsor:
Hadassah Medical Organization
Treatments:
Lenograstim